Ph-responsive galactosylated chitosan-polyethylene glycol polymer bonded doxorubicin prodrug and its preparation and use

A technology of polyethylene glycol and chitosan, which is applied in the fields of polymer materials and biomedical engineering, can solve the problems of small drug loading, uncertain drug loading, and the release rate of drugs cannot be released quickly, so as to reduce toxicity. , the effect of good pH responsiveness

Inactive Publication Date: 2019-01-18
CENT SOUTH UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In the existing methods of using polymer micelles as drug carriers, most of the drugs are physically entrapped. Generally, the hydrophobicity of the drug is used to make the interaction between the drug and the hydrophobic group of the carrier enter the core. Certain disadvantages such as definite or relatively small drug load; there are also chemical bonding methods to directly connect the drug to the hydrophobic end. In CN101564539A, cis-aconitic anhydride is used to link doxorubicin and chitosan with amide bonds. In this case, when loaded After the drug-loaded micelles enter the body, the amide bond is difficult to be hydrolyzed, resulting in a slow release of the drug and a low release rate. Therefore, the bioavailability of the drug-loaded micelles decreases.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ph-responsive galactosylated chitosan-polyethylene glycol polymer bonded doxorubicin prodrug and its preparation and use
  • Ph-responsive galactosylated chitosan-polyethylene glycol polymer bonded doxorubicin prodrug and its preparation and use
  • Ph-responsive galactosylated chitosan-polyethylene glycol polymer bonded doxorubicin prodrug and its preparation and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Preparation of galactosylated chitosan-polyethylene glycol polymer:

[0025] (1) Galactosylation of chitosan: Weigh 3.2g of commercially available chitosan in 2% (v / v) 60ml acetic acid aqueous solution, stir at room temperature for 1h, after chitosan is fully swollen, add 0.3 g lactose, stirred in a water bath at 40°C for 24 hours, added a weak reducing agent sodium cyanoborohydride and stirred for 1 hour, put the reaction solution in a dialysis bag (MWCO=3500), dialyzed with distilled water, and freeze-dried to obtain a galactosified shell glycans. The grafting rate of galactose was measured by sulfuric acid phenol method, and the grafting rate of galactose in the obtained galactosylated chitosan was determined to be 0.315%.

[0026] (2) Carboxylation of monomethyl ether polyethylene glycol: Weigh 1.4 g of monomethyl ether polyethylene glycol and 0.426 g of 3,3'-dithiodipropionic anhydride, dissolve in molecular sieve-dried N,N-dipropionic anhydride Add 4-dimethylami...

Embodiment 2

[0049] Prepare galactosylated chitosan and carboxylated polyethylene glycol according to the same method in Example 1, accurately weigh galactosylated chitosan 1.0g, carboxylated polyethylene glycol 0.417g, and add 1-ethylene glycol Base-(3-dimethylaminopropyl) carbodiimide hydrochloride was stirred and reacted for 48h. After the reaction, the reaction solution was placed in a dialysis bag, dialyzed with distilled water, and freeze-dried to obtain galactosylated chitosan-polyethylene Glycol polymer.

[0050] Amino protection with doxorubicin was carried out under the same conditions as in Example 1. Formylation of histidine: Weigh 0.1648 g of histidine and add it into the ethanol solution of KOH (solution A), and stir until completely dissolved. Measure 2ml of glutaraldehyde (containing 0.5g of glutaraldehyde) and dissolve it in ethanol (solution B), and heat to 40°C. The A solution was slowly added dropwise to the B solution, and the addition was completed within 0.5h, and ...

Embodiment 3

[0052] The galactosylation of chitosan: take by weighing commercially available chitosan 3.2g in the 60ml acetic acid aqueous solution of 2% (v / v), stir 1h under normal temperature, after chitosan is fully swollen, add 0.2g lactose, Stir in a water bath at 35°C for 36 hours, add weak reducing agent sodium cyanoborohydride and stir for 1 hour, place the reaction solution in a dialysis bag (MWCO=3500), dialyze with distilled water, freeze-dry to obtain galactosylated chitosan, spare. The grafting rate of galactose was measured by sulfuric acid phenol method, and the grafting rate of galactose in the obtained galactosylated chitosan was determined to be 0.275%.

[0053] Prepare carboxylated polyethylene glycol according to Example 1, accurately weigh galactosylated chitosan 1.0g, carboxylated polyethylene glycol 0.625g, and add 1-ethyl-(3-dimethylaminopropyl ) carbodiimide hydrochloride was stirred and reacted for 48 hours. After the reaction, the reaction solution was placed in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to a galactosylated chitosan-polyethylene glycol polymer and adriamycin bonded pro-drug having pH response and neighboring group effects as well as a preparation method and applications of the pro-drug in medicines. The preparation method is characterized by comprising the following steps: (1) carrying out carboxylation on monomethoxyl polyethylene glycol, and enabling the carboxylated monomethoxyl polyethylene glycol to form amido bonds with amino groups in galactosylated chitosan, thus preparing a chitosan-polyethylene glycol drug carrier; (2) enabling amino groups in histidine to react with glutaraldehyde to obtain histidine containing aldehyde groups; (3) carrying out protection on amino groups on adriamycin, carrying out an esterification reaction between carboxyl groups of the histidine and hydroxyl groups in adriamycin, and carrying out deprotection; (4) carrying out a Schiff base reaction of aldehyde-group-containing histidine adriamycin ester and chitosan-polyethylene glycol, and carrying out reduction by adopting sodium cyanoborohydride; and (5) preparing drug-loading micelles by adopting a dialysis method, wherein the prepared drug-loading micelles have good pH response and good liver targeting ability, and can be further researched and developed into a novel targeting preparation for treating liver cancer.

Description

technical field [0001] The present invention relates to a prodrug of polymer-bonded doxorubicin, in particular to a chemically bonded prodrug of chitosan-polyethylene glycol graft with pH responsiveness and antitumor drug doxorubicin, and its The preparation method and the application in medicine belong to the fields of polymer materials and biomedical engineering. Background technique [0002] Malignant tumor is a major disease that seriously threatens human life, and liver cancer is one of the common digestive system tumors. Doxorubicin is an anthracycline antineoplastic drug commonly used in clinical practice. It can be embedded in DNA, prevent RNA transcription, inhibit RNA synthesis, and prevent DNA replication. Doxorubicin has a broad antitumor spectrum and high curative effect, and is mainly used for malignant lymphosarcoma, breast cancer, ovarian cancer, small cell lung cancer, gastric cancer, liver cancer and bladder cancer. However, small molecule drugs are easil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): A61K9/10A61K31/704A61K47/61A61K47/60A61P35/00
CPCA61K31/704
Inventor蒋玉仁汪金连邓友超
OwnerCENT SOUTH UNIV